|Journal Name||Molecular Cancer|
|Journal Start Year||2002|
|Impact Factor||10.679 (2018)|
|Country||United Kingdom (GB)|
|Journal Details||Journal Website|
Impact factor :
Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.
Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.
Molecular Cancer provides an important forum for exciting findings in cancer-related research, presenting an unparalleled opportunity to communicate information to specialists and the public. The online appearance of Molecular Cancer allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community.
All articles published in Molecular Cancer are included in:
The abbreviation of the journal is Mol Cancer. find all journal abbreviation lists from the abbreviation list.
The Journal has been published since 2002.
BioMed Central is the publisher of the Molecular Cancer. find all journals list from BioMed Central publisher, click here for a list of journals.
The journal is currently publishing 18 volumes with the help of BioMed Central publisher.
"Molecular Cancer" journal , and Online ISSN 1476-4598
Yes this journal is indexed in UGC Journal list. you also can visit in UGC care list, may be they have updated their list. get a list of ugc approved journals.
Yes the journal is PUBMED indexed journal.
Yes this journal is peer reviewed journal and published by BioMed Central.
The Journal is indexed in Pubmed, Scopus, UGC (University Grants Commission).
The Journal Impact factor is 10.679 (2018).
Journal of Cancer and Tumor International (ISSN: 2454-7360) aims to publish high quality papers (Click here for Types of paper) in all areas of ‘Cancer and Tumor research’. This journal facilitates the research and wishes to publish papers as long as they are technically correct, scientifically motivated. The journal also encourages the submission of useful reports of negative results. This is a quality controlled, OPEN peer reviewed, open access International journal. This journal will have 4 issues per year. Each issue will be running issue and all officially accepted manuscripts will be immediately published online. State-of-the-art running issue concept gives authors the benefit of 'Zero W...
Indian Journal of Cancer (ISSN 0019-509X), the show window of the progress of oncological sciences in India, was established in 1963. Indian Journal of Cancer is the first and only periodical serving the needs of all the specialties of oncology in India. Its international repute is recognized by its indexing with most bibliographic databases including MEDLINE, Index Medicus, EMBASE and Biological Abstracts. The journal is the official publication of the Indian Cancer Society. The readership has expanded beyond the boundaries of the country. Apart from the journal's own website, the internet issue of the journal has been made available in collaboration with Bioline International, Canada. The journal's content...